Jonathan Eckard, Ph.D.

Go-getter
DISC Type : d

Management Consultant at PeragoBio Consulting

Summit, New Jersey, United States

Overview

Jonathan Eckard is a biopharma executive with 20 years of experience in corporate strategy and deal execution, specializing in oncology and metabolic diseases. He integrates deep scientific due diligence with a background in Wall Street equity research to lead M&A and licensing. He holds a Ph. D. from the NYU Grossman School of Medicine.

He frequently shares insights on biopharmaceutical regulatory changes, trade policies, and the impact of geopolitical events on the industrys supply chain. His posts demonstrate a keen interest in analyzing and explaining complex market and regulatory dynamics affecting life sciences companies, keeping his network informed on pivotal industry shifts.

His unique career path includes transitioning from a senior biotechnology analyst at top-tier investment banks like Barclays and Citi to C-suite roles in several biopharma companies.

Personality Overview

Challenger

Fast-Paced

Direct & Candid

They don’t always try to control the conversation but neither do they like yielding it fully.  They focus on objectivity in a pitch and pay little attention to bells and whistles. They care equally about the product and its potential impact.

Topics They Care About

Biopharma Regulation
Regularly posts detailed weekly briefings and updates on FDA programs, trade policies, and other regulatory changes impacting the biopharmaceutical industry.
M&A and Licensing
His career is centered on leading end-to-end M&A and business development and licensing (BD&L) initiatives for life sciences companies.
Capital Raising
Focuses on capital strategies, including private financing and IPO preparation, leveraging his Wall Street background to advise life sciences firms.

Media Appearances

Jonathan has no verified media appearances

Work History

9-2022
Management Consultant at PeragoBio Consulting
8-2017 - 9-2022
Acting Chief Financial Officer- Chief Business Officer at Tyme Inc
10-2016 - 8-2017
Chief Business & Strategy Officer at Sellas Life Sciences
3-2015 - 10-2016
Director, Small and Mid-Cap Biotechnology Research at Barclays
7-2012 - 3-2015
Director, Small and Mid-Cap Biotechnology Research at Citi

Education

2000 - 2005
PH.D. from NYU Grossman School of Medicine
9-1992 - 6-2016
Bachelor of Science - BS from Ohio University

More Information

Social Presence :

Prographics :

Exp : 20 Location : Summit, New Jersey, United States Job Level : N/A Designation : Management Consultant at PeragoBio Consulting
URL has been copied!

Insights For Selling To Jonathan

During A Call Or A Meeting

DO's

  • Make sure that you you respond to any queries from them quickly
  • Stress on the business value that your product offers
  • Tell them that you are there to help them create visible impact within their organization

DONT's

  • Refrain from asking too many questions
  • Avoid long winding pitches, stay objective
  • Don't try too hard to get friendly, let it happen with time

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Jonathan is

  • Confidence in the product plays an important role, followed by powerful testimonials.
  • Will you ever get a clear answer from Jonathan

  • They might hesitate a little, but they will say no if they are not convinced.

Insights For Deal Planning

    How fast (or slow) will Jonathan move?

  • They are neither the fastest decision makers nor the slowest.
  • Can Jonathan take some risk or not?

  • Once they have analyzed the pros and cons, they can take some risks.

You And Jonathan

Personality Compatibility


More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.